Recent Episodes
CAR T-cell Therapy in 2022: What You Need to Know Part II
Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX
Everything You Need to Know About Cutaneous T-cell Lymphoma
Francine Foss, MD and John A. Zic, MD, MMHC
A Deep Dive into Myelofibrosis
Srdan Verstovsek, MD, PhD, MD Anderson Cancer Center, Houston, TX
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
CAR T-cell Therapy in 2022: What You Need to Know
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA
Highpoints from Attending the 2021 American Society of Hematology Conference
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Categories
- All Episodes (84)
- CAR T-cell Therapy (10)
- Clinical Trials (4)
- COVID-19 (7)
- General Treatment & Support (26)
- Genomics (3)
- Health Equity (6)
- Leukemia (19)
- Lymphoma (10)
- Minimal Residual Disease (MRD) (3)
- Myelodysplastic Syndromes (5)
- Myeloma & Amyloidosis (10)
- Myeloproliferative Neoplasms (3)
- Pediatric and AYA (12)
- Rare Blood Cancers (4)
- Transplantation (4)
- Waldenström macroglobulinemia (2)
